Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina

BACKGROUND: Glycosylated hemoglobin A1C (HbA1c) has been widely recognized as a marker for predicting the severity of diabetes mellitus (DM) and several cardiovascular diseases. However, whether HbA1c could predict the severity and clinical outcomes in patients with stable coronary artery disease (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Li-Feng, Li, Xiao-Lin, Guo, Yuan-Lin, Luo, Song-Hui, Zhu, Cheng-Gang, Qing, Ping, Xu, Rui-Xia, Wu, Na-Qiong, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070346/
https://www.ncbi.nlm.nih.gov/pubmed/24884794
http://dx.doi.org/10.1186/1476-511X-13-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070346/
https://www.ncbi.nlm.nih.gov/pubmed/24884794
http://dx.doi.org/10.1186/1476-511X-13-89

Ejemplares similares